menu
    • menu

    Company profile for KalVista Pharmaceuticals

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    KalVista is a pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases with significant unmet need. Our initial focus is on inhibitors of plasma kallikrein, which is an important component of the body’s inflammatory response and which, in excess, can lead to increased vascular permeability, edema and inflammation. We have developed...
    KalVista is a pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases with significant unmet need. Our initial focus is on inhibitors of plasma kallikrein, which is an important component of the body’s inflammatory response and which, in excess, can lead to increased vascular permeability, edema and inflammation. We have developed a proprietary portfolio of novel, small molecule plasma kallikrein inhibitors initially targeting hereditary angioedema (HAE) and diabetic macular edema (DME).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    KalVista PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    55 Cambridge Pkwy Cambridge, Massachusetts 02142
    Telephone
    Telephone
    1 (857) 999 0075
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kalvista.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kalvista-pharmaceuticals-limited/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/kalvista?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kalvista Pharma Updates Operations, Reveals Q3 Financials Update
    Kalvista Pharma Updates Operations, Reveals Q3 Financials Update

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251110740627/en/KalVista-Pharmaceuticals-Provides-Operational-Update-and-Reports-Third-Quarter-Financial-Results

    BUSINESS WIRE
    10 Nov 2025
    Share Share
    KalVista Shares EKTERLY Data Showing High Patient Satisfaction
    KalVista Shares EKTERLY Data Showing High Patient Satisfaction

    06 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251106901557/en/KalVista-Pharmaceuticals-Presents-New-Data-Highlighting-Patient-Satisfaction-with-EKTERLY-sebetralstat-and-its-Potential-in-Children-Ages-2-11-at-the-ACAAI-2025-Annual-Scientific-Meeting

    BUSINESS WIRE
    06 Nov 2025
    Share Share
    Kalvista Pharma To Present at Upcoming Investor Conferences
    Kalvista Pharma To Present at Upcoming Investor Conferences

    05 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251105630013/en/KalVista-Pharmaceuticals-to-Present-at-Upcoming-Investor-Conferences

    BUSINESSWIRE
    05 Nov 2025
    Share Share
    Kalvista Pharma To Host Q3 Financial Results Conference Call
    Kalvista Pharma To Host Q3 Financial Results Conference Call

    03 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251103214409/en/KalVista-Pharmaceuticals-to-Host-Third-Quarter-Financial-Results-Conference-Call-and-Webcast-on-November-11-2025

    BUSINESSWIRE
    03 Nov 2025
    Share Share
    Kalvista Pharma to Unveil Ekterly Data at ACAAI 2025 Meeting
    Kalvista Pharma to Unveil Ekterly Data at ACAAI 2025 Meeting

    30 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251030981394/en/KalVista-Pharmaceuticals-to-Present-New-EKTERLY-sebetralstat-Data-at-the-American-College-of-Allergy-Asthma-Immunology-2025-Annual-Scientific-Meeting

    BUSINESSWIRE
    30 Oct 2025
    Share Share
    Kalvista Pharma Names Bilal Arif COO & Linea Aspesi CPO
    Kalvista Pharma Names Bilal Arif COO & Linea Aspesi CPO

    06 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-06/kalvista-pharmaceuticals-appoints-bilal-arif-as-chief-operating-officer-and-linea-aspesi-as-chief-pe

    PHARMIWEB
    06 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search